Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by wetbehindearson Apr 22, 2021 5:50am
219 Views
Post# 33042932

RE:RE:RE:RE:April 28, 2021, VOTE @ the Meeting ℹNO SHARE SPLIT

RE:RE:RE:RE:April 28, 2021, VOTE @ the Meeting ℹNO SHARE SPLIT

Let me be clear...I am not selling. I am in it for the long haul.  But the journey is frustrating. 

Even for a 10:1 reverse split to happen, the stock needs to go up first. It simply would be a failure to the investors if the rs happened without an increase first. I also understand the shorters selling etc. But while a million shares at 0.05 is worth the same as 100k shares at 0.50 or even  50k shares at 1$, any marginal increase after the split has way less impact on the value of our overall personal stock value. Having the rs happen before seeing value rise just seems crazy to me when the actual value of this stock seems so undervalued based on what it is. 

I have seen people list their selling price at over 1$. After a 10:1 reverse split, the stock value would need to reach 10$ for it to be the same value. 

If the reverse split needs to happen in order to make it fly, NO PROBLEM with me. But it's a shame it cannot go up now because it seems completely undervalued and the news releases are not strong or effective enough. For something I consider to be this strong, that is a failure. 

I have confidence still in the BOD and it is a strong group. But I'd like to also see them invest and stake their claim in the confidence of the company and see this rise on its own merits before the rs. 

long winded this morning...lol. Just tired of being halted, having confidence and feeling like being on a yo yo when I truly believe we should feel like we are on a kite!  I'm not selling.  I'm holding.  Just need to see more!

<< Previous
Bullboard Posts
Next >>